Publish in this journal
Journal Information
Vol. 68. Issue 11.
Pages 1039 (November 2015)
Vol. 68. Issue 11.
Pages 1039 (November 2015)
Letter to the Editor
Full text access
Does Educational Level Predict Mortality After Myocardial Infarction Independently of Left Ventricular Function and Medical Treatment?
¿El nivel de estudios predice la mortalidad tras un infarto de miocardio de manera independiente de la función ventricular izquierda y del tratamiento médico?
Mehmet Eyuboglu
Department of Cardiology, Dinar State Hospital, Dinar, Afyonkarahisar, Turkey
Related content
Luciano Consuegra-Sánchez, Antonio Melgarejo-Moreno, José Galcerá-Tomás, Nuria Alonso-Fernández, Ángela Díaz-Pastor, Germán Escudero-García, Leticia Jaulent-Huertas, Marta Vicente-Gilabert
Luciano Consuegra-Sánchez, Leticia Jaulent-Huertas, Marta Vicente-Gilabert, Antonio Melgarejo-Moreno
Article information
Full Text
Download PDF
Full Text
To the Editor,

I read the article by Consuegra-Sánchez et al1 with great interest. In their study, the authors report an inverse and independent relationship between educational level and long-term mortality in post-myocardial infarction patients. I would like to make a few points about the methodology and results of the article.1 In their study, the authors report the mean left ventricular ejection fraction (LVEF) of all patients and indicate LVEF as a predictor of long-term mortality. However, there are no data about the mean LVEF for each group. It is known that LVEF < 40% is an independent predictor of mortality after myocardial infarction.2 Therefore, the authors should state the mean LVEF and incidence of patients with LVEF < 40% for each group and compare the mean LVEF among the groups. A higher incidence of patients with LVEF < 40% in illiterate and primary education patient groups may be another significant reason for higher mortality rates. Additionally, the study by Consuegra-Sánchez et al1 includes patients with impaired left ventricle systolic function (mean LVEF=49% for all patients). Aldosterone antagonists significantly reduce all-cause mortality in post-myocardial infarction patients with LVEF < 40%, in addition to standard medical therapy.3 In the study by Consuegra-Sánchez et al,1 there are no data on the incidence of patients treated with aldosterone antogonists. A higher incidence of treatment with aldosterone antagonists in secondary education and higher education patient groups may be the reason for lower mortality rates.

In conclusion, low educational levels may be associated with adverse outcomes in post-myocardial infarction patients. However, LVEF and aldosterone antagonists may still have an effect on the results of the study by Consuegra-Sánchez et al.1 To indicate low levels of education as a predictor of mortality, it should be proven that there were no differences in the mean LVEF of all patient groups and that all patient groups were treated similarly with all medications that are known to reduce mortality in post-myocardial infarction patients.

L. Consuegra-Sánchez, A. Melgarejo-Moreno, J. Galcerá-Tomás, N. Alonso-Fernández, Á. Díaz-Pastor, G. Escudero-García, et al.
Nivel de estudios y mortalidad a largo plazo en pacientes con infarto agudo de miocardio.
Rev Esp Cardiol., 68 (2015), pp. 935-942
The Multicenter Postinfarction Research Group.
Risk Stratification and Survival after Myocardial Infarction.
N Engl J Med., 309 (1983), pp. 331-336
B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators, et al.
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
N Engl J Med., 348 (2003), pp. 1309-1321
Copyright © 2015. Sociedad Española de Cardiología
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

View newsletter history
Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?